The largest database of trusted experimental protocols

11 protocols using polyu

1

Dendritic Cell Preparation for Cancer Vaccine

Check if the same lab product or an alternative is used in the 5 most similar protocols
Preparation of BM-DC is adapted from published protocols.56 57 (link) Briefly, the development of dendritic cells (DC) from murine bone marrow (BM) progenitor cells was performed as previously published.56 57 (link) BM cells were cultured overnight in DMEM (Life Technologies) with 10% FCS (fetal calf serum), 1% penicillin, streptomycin, and amphotericin in a Petri dish. On day 1, cells were cultured with murine IL4 (500 U/mL;) and murine GM-CSF (20 ng/mL; both cytokine from ImmunoTools) for 5 days. Non-adherent cells were then re-plated at 1×105 cells/well in 6-well plates and resuspended at 2×106 to 5×106 cells/mL in serum-free DMEM and loaded with lysates from indicated TC1 (lysate from 1×104 TC1/4×104 BM-DC/mouse; Gal-3HIGH-vaccine: lysate with TC1-shCtrl; Gal-3LOW-vaccine: lysate with TC1-shGal-3 or TC1-shCtrl pretreated in vitro for 15 days by LDD) in serum-free media for 3 hours at 37°C (5% CO2), and then adjuvants (PolyU-PEI (1:15; 20 µg/mL PolyU, Sigma)+CpG (2 ng/mL; IDT)) was added to allow an overnight maturation of BM-DC before mice injection.
+ Open protocol
+ Expand
2

Biochemical Reagent Preparation for Enzyme Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise specified, all reagents were of the highest available purity. Peptides were custom synthesized and purified by GenScript, Hong Kong. 4-MUG and 4-MU were purchased from Rhenium. β-galactosidase from E-coli and Atto633 protein labeling kit and poly-U were purchased from Sigma. NaCl, NaOH, and HCl were purchased from Biolab. Sodium Phosphate monobasic and Sodium Phosphate dibasic for phosphate buffer preparation were purchased from Holland Moran.
+ Open protocol
+ Expand
3

Ribosome Binding Assay for Upf1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ribosomal subunits from S. cerevisiae were purified as previously reported (45 (link)), or from Escherichia coli as previously reported (59 (link)). Ribosome pelleting assays were conducted by incubating ribosomal subunits with Upf1 proteins in reactions containing 100 nM 40S and 60S ribosomal subunits, 100 nM Upf1, 1 mM nucleotide, and 0.2 mg/ml polyU (Sigma) in 1X Buffer E (20 mM Tris, pH 7.5, 100 mM KOAc pH 7.5, 2.5 mM Mg(OAc)2, 0.25 mM spermidine and 2 mM DTT). Reactions were pelleted over sucrose cushions containing 1.1 M sucrose in Buffer E using a Beckman MLA-130 rotor at 75 000 rpm for 1 hour at 4°C. Pelleted ribosomes were resuspended in Buffer E and run on SDS-PAGE gels for Western blotting using an anti-MBP antibody (NEB) to detect Upf1.
+ Open protocol
+ Expand
4

Murine BM Activation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine bone marrow (BM) cell suspensions were activated with a preparation of oligonucleotides PolyU (Sigma-Aldrich) with 1,2-dioleoyloxy-3-trimethylammonium-propane (DOTAP) (8 μl of a cationic liposome preparation (DOTAP; Roche) mixed with 1 μg of PolyU in 150 μl of RPMI, in a polystyrene tube). BM cells were stimulated PolyU-DOTAP preparation for 4 hours and 5μg/ml brefeldin A (eBiosciences) was added for the last 2 h of culture. Non-specific staining was blocked with 5μg/ml anti-CD16/CD32 (2.4G2, American Type Culture Collection). BM cell suspensions were then stained with PE-Cy7-labeled anti-CD11c (N418) and APC-labeled mPDCA1 (all from eBiosciences). Intracellular cytokine staining was performed with mixed FITC–labeled IFNα/β–specific antibodies (RMMA-1/RMMB-1; PBL). Unstimulated cells and isotypes were used as control staining. Data were acquired on a Fortessa (BD Biosciences).
+ Open protocol
+ Expand
5

Dendritic Cell Vaccination for Anti-Tumor Immunity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dendritic cells (DC) were prepared from C57BL/6 bone marrows as previously described (33 (link)). Briefly, bone marrow cells were flushed with ice-cold PBS and erythrocytes lysed using ACK buffer (8.7 g/L NH4Cl, 1g/L KHCO3, 0.05 mM EDTA, pH 7.3). Cells were cultured in DMEM 20% heat-inactivated FBS (Gibco), 1mM sodium piruvate, 2 mM glutamine and antibiotics (1 U/ml penicillin, 1 μg/ml streptomycin) (Invitrogen), in presence of 20 ng/mL mrGM-CSF and 10 ng/mL mrIL-4 (ImmunoTools). Cells were cultured for 5 days, with addition of GM+IL-4 every 2 days. Immature DCs were pulsed during 5 h with TRAMP-C1 lysates (4 freeze/thawing steps), and then matured with 2 ng/mL CpG-1826 (phosphorothioate 5'-TCCATGACGTTCCTGACGTT-3', IDT) and 20 μg/mL Poly-U (Sigma-Aldrich) during an overnight culture. To obtain experienced anti-tumor lymphocytes, wild type or Lgals1-/- mice were s.c. immunized with tumor lysate-pulsed dendritic cells. At day 7 pot-immunization, lymphocytes obtained from axillary, brachial and inguinal lymph nodes were used for immune reconstitution of nude mice.
+ Open protocol
+ Expand
6

Isolation and Purification of mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from HeLa cells using the RNeasy Mini Kit (QIAGEN). mRNA was isolated from total RNA using the DynabeadsTM mRNA purification Kit (ThermoFisher). The tangled total RNA was prepared according to published work [20 (link)]. Poly(A) (Sigma-Aldrich, Cat#10108626001), Poly(C) (Sigma-Aldrich, Cat#P4903), Poly(G) (Sigma-Aldrich, Cat#P4404), Poly(U) (Sigma-Aldrich, Cat#P9528), and Ribosomal RNA (Bioworld, Cat#11020001-2) were all purchased. The 5’UTR-KpnB1-nanoLUC mRNA was transcribed with an mMESSAGE T7 kit (Invitrogen).
+ Open protocol
+ Expand
7

Measurement of DHX36 ATP Hydrolysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
DHX36 was incubated in K-Res buffer with 0.01 mM ATP spiked with 50 nCi [γ-32P]-ATP in the presence of either poly(U) (100 ng·μl−1, Sigma) or 100 nM Z33 G4 and 5 μM ligand. At indicated times, reactions were stopped by adding EDTA (0.5 M, 1 μl, pH 8.0) to a 5 μl aliquot of reaction. ATP hydrolysis was quantified by CEL PEI/UV254 TLC plates (Polygram) in 0.8 M acetic acid/0.8 M LiCl aqueous running solution after washing in methanol. TLC plates were air dried. Imaging was as for PAGE. Hydrolysis data were fit with one-phase exponential decay. One-way ANOVA was used to assess the significance of ATP hydrolysis data.
+ Open protocol
+ Expand
8

Synthetic CXCL14 Chemokine Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endotoxin-free ODN2395 was purchased from InvivoGen (San Diego, CA). ODN2395mut (phosphorothioester modified sequence), 5′Cy3-ODN2395, 5′Cy3-ODN2395(p), 5′Cy3-ODN2395mut(p), ODN1826, ODN1826(p), 5′Cy3-ODN1826, 5′Cy3-ODN1826(p), ODN1585(p), 5′Cy3-ODN1585(p), ODN-D-SL03, 5′Cy3-ODN-D-SL03, ODN21798, 5′Cy3-ODN21798, ODN1668, ODN1668(p), 5′Cy3-ODN1668, 5′Cy3-ODN1668(p), and 5′Cy3-D35 were synthesized by Eurofins Genomics (Tokyo, Japan). D35 was purchased from Gene design (Osaka, Japan). CXCL14, CXCL14-K-biotin (referred to as CXCL14-bio in this study), and CXCL14-Alexa488 were chemically synthesized (Tsuji et al., 2015 (link)) based on the human CXCL14 sequence (Supplementary methods and Fig. S1). Synthetic CXCL14 was as active as recombinant CXCL14 in terms of the inhibition of CXCL12-mediated cell migration. The endotoxin level of the synthetic CXCL14 preparation was < 0.1 EU/mg, as measured by a LAL Quantitation Kit (Thermo Fisher Scientific). LPS, Poly-U, and Poly-IC were purchased from Sigma-Aldrich (St. Louis, MO).
+ Open protocol
+ Expand
9

Tau Protein Aggregation Kinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tau protein was incubated at 20 μM in 384-well low-volume
microplate with 20 μM ThT. The RNA polyC (Sigma P4903), polyA
(Roche 10108626001) or polyU(Sigma P9528) were added at 200 μM.
Heparin (Sigma H6279) was added at a concentration of 5 μM in
supplementary experiments (Figure S11).
The working volume was 20 μL. The fluorescence was bottom read
in a BMG fluoroStar Omega instrument with excitation and emission
wavelengths of 440 and 480 nm, respectively. Each condition was prepared
independently in three or two different wells.
ThT kinetic curves
were first normalized between 0 and 1. They were then fitted using
the curve_fit python function with the following
equation: where F represents the final
fluorescent intensity, k represents the growth rate,
and t1/2 represents the aggregation halftime.
Each replicate was fitted independently. The presented error bars
on the aggregation halftimes represent the standard deviation over
the output t1/2 obtained from the fit
of each replicate. The fitting functions are shown in Figure S3. tau187-WT signal was normalized with
the maximum intensity of tau187-P301L for visualization in Figure 2A, since it did not
increase.
+ Open protocol
+ Expand
10

Nonspecific RNA Binding Assay of DRG1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The nonspecific RNA binding ability of DRG1 proteins was assayed in vitro as described7 (link),69 (link). Briefly, 0.5 mg of proteins were incubated in 100 µL of cold reaction buffer (10 mM HEPES–NaOH (pH 7.4), 100 mM NaCl, 2 mM MgCl2, 0.1% Triton X-100, 3 mM DTT) with a free poly(U) (Sigma-Aldrich) at concentrations of 0, 0.1 and 1 mg/mL. The reactions were incubated for 30 min at 4 °C in the rotator. Subsequently, 10 µL of 50% poly(U)-agarose (Sigma Aldrich) in binding buffer was added to each reaction mixture and incubated for 30 min at 4 °C. The beads were washed six times in binding buffer following centrifugation for 1 min at 4 °C. Finally, proteins bound to the poly(U)-agarose were eluted by adding 10 µL of 4 × SDS sample buffer and boiled at 95 °C for 6 min. Samples were loaded onto a 12% SDS-PAGE gel and visualized by Coomassie brilliant blue.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!